Luminex develops, manufactures and sells biological testing technologies and products with applications in the life sciences industries, including diagnostics, pharmaceutical and research. Co. delivers its products to various market segments, including multiplexing, reduction of labor and ability to test for proteins and nucleic acids. Co.'s products include: instruments, which include Luminex® 100/200, FLEXMAP® 3D, MAGPIX®, ARIES®, and ARIES® M1; consumables, which include MicroPlex® Microspheres, MagPlex® Microspheres, and xTAG® Microspheres; software, which includes xPONENT®, TDAS®, SYNCT, and IDEAS®; and clinical diagnostic assay product families, which include ARIES® Cassettes. When considering the Luminex Corp stock dividend history, we have taken known splits into account, such that the LMNX dividend history is presented on a split-adjusted ("apples to apples") basis. Luminex Corp dividend history is presented both in graphical/chart form, and as a LMNX dividend history data table along the right-hand column.
|
LMNX Stock Dividend HistoryThe LMNX dividend history graphic shown above is presented after taking into consideration any known stock split occurrences, in order to present the most directly comparable LMNX historical dividend comparison possible. Historical dividends, when charted graphically, can reveal the long-term variability and/or growth within the LMNX dividend history record. Also see the LMNX stock dividend history data table along the right-hand column below. |
|
LMNX Next Dividend Date » (Projection based upon history) Quotes delayed 20 minutes |
Hold (2.00 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Analysts' Target Price: LMNX Forecast Based on data provided by Zacks Investment Research via Quandl.com |
Projection: LMNX Next Dividend Date Chart: LMNX Chart - 5Yr Dividend Yield |